Haplotypes extending across ACE are associated with Alzheimer's disease

Human Molecular Genetics

Volumn 12, Issue 8, 2003, Pages 859-867

  Kehoe, Patrick G ^a   Katzov, Hagit ^b   Feuk, Lars ^b   Bennet, Anna M ^b   Johansson, Boo ^c   Wilman, Björn ^d   de Faire, Ulf ^b,d   Cairns, Nigel J ^e   Wilcock, Gordon K ^a   Brookes, Anthony J ^b   Blennow, Kaj ^f   Prince, Jonathan A ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; DNA MARKER;

ALLELE; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE INSERTION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METABOLISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALZHEIMER DISEASE; HAPLOTYPES; HUMANS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

INSERTION SEQUENCES;

EID: 0242600651     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg094     Document Type: Article

References (54)

1. Goate, A., Chartier-Harlin, M.C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L. et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature, 349, 704-706.
2. Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li. G., Holman, K. et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 375, 754 760.
3. Rogaev, E.I., Sherrington, R., Rogaeva, E.A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T. et al. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature, 376, 775-778.
4. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S. and Roses, A.D. (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl Acad. Sci. USA, 90, 1977-1981.
5. Haines, J.L., Bailey, L.R., Grubber, J.M., Hedges, D., Hall, J.L., West, S., Santoro, L., Kemmerer, B., Saunders, A.M., Roses, A.D. et al. (2001) A genomic screen for Alzheimer's Disease genes. In Iqbal K., Sidsodia S.S., Winblad, B. (eds), Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics. J Wiley, New York, pp. 33-43.
6. Terwilliger, J.D. and Weiss, K.M. (1998) Linkage disequilibrium mapping of complex disease: fantasy or reality? Curr. Opin. Biotechnol., 9, 578-594.
7. Pritchard, J.K. and Cox, N.J. (2002) The allelic architecture of human disease genes: common disease-common variant or not? Hum. Mol. Genet., 11, 2417-2423.
8. Steinmetz, L.M., Sinha, H., Richards, D.R., Spiegelman, J.I., Oefner, P.J., McCusker, J.H. and Davis, R.W. (2002) Dissecting the architecture of a quantitative trait locus in yeast. Nature, 416, 326-330.
9. Altshuler, D., Hirschhorn, J.N., Klannemark, M., Lindgren, C.M., Vohl, M.C., Nemesh, J., Lane, C.R., Schaffner, S.F., Bolk, S., Brewer, C. et al. (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet., 26, 76-80.
10. Meijers-Heijboer, H., Van Den Ouweland, A., Klijn, J., Wasielewski, M., De Snoo, A., Oldenburg, R., Hollestelle, A., Houben, M., Crepin, E., van Veghel-Plandsoen M. et al. (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet., 31, 55-59.
11. Hugot, J.P., Chamaillard, M., Zouali. H., Lesage, S., Cezard, J.P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C.A., Gassull, M. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 411, 599-603.
12. Weiss, K.M. and Clark, A.G. (2002) Linkage disequilibrium and the mapping of complex human traits. Trends Genet., 18, 19-24.
13. Akey, J., Jin, L. and Xiong, M. (2001) Haplotypes vs single marker linkage disequilibrium tests: what do we gain? Eur. J. Hum. Genet., 9, 291-300.
14. Lehmann, D.J., Williams, J., McBroom, J. and Smith, A.D. (2001) Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups. Neuroscience, 105, 541-554.
15. Narain, Y., Yip, A., Murphy, T., Brayne, C., Easton, D., Evans, J.G., Xuereb, J., Cairns, N., Esiri, M.M., Furlong, R.A. et al. (2000) The ACE gene and Alzheimer's disease susceptibility. J. Med. Genet., 37, 695-697.
16. Sanchez-Guerra, M., Combarros, O., Infante, J., Llorca, J., Berciano, J., Fontalba, A., Fernandez-Luna, J.L., Pena, N. and Fernandez-Viadero, C. (2001) Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease. Neurosci. Lett., 316, 17-20.
17. Keavney, B., McKenzie, C.A., Connell, J.M., Julier, C., Ratcliffe, P.J., Sobel, E., Lathrop, M. and Farrall, M. (1998) Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum. Mol. Genet., 7, 1745-1751.
18. Rieder, M.J., Taylor, S.L., Clark, A.G. and Nickerson, D.A. (1999) Sequence variation in the human angiotensin converting enzyme. Nat. Genet., 22, 59-62.
19. Farrall, M., Keavney, B., McKenzie, C., Delepine, M., Matsuda, F. and Lathrop, G.M. (1999) Fine-mapping of an ancestral recombination breakpoint in DCP1. Nat. Genet., 23, 270-271.
20. Hu, J., Igarashi, A., Kamata, M. and Nakagawa, H. (2002) Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J. Biol. Chem., 276, 47863-47868.
21. Niu, T., Qin, Z.S., Xu, X. and Liu, J.S. (2002) Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am. J. Hum. Genet., 70, 157-169.
22. Johnson, G.C., Esposito, L., Barratt, B.J., Smith, A.N., Heward, J., Di Genova, G., Ueda, H., Cordell, H.J., Eaves, I.A., Dudbridge, F. et al. (2001) Haplotype tagging for the identification of common disease genes. Nat. Genet., 29, 233-237.
23. Hill, W.G. (1974) Estimation of linkage disequilibrium in randomly mating populations. Heredity, 33, 229-239.
24. Yusuf, S., Peto, R., Lewis, J., Collins, R. and Sleight, P. (1985) Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog. Cardiovasc. Dis., 27, 335-371.
25. Andreasen, N., Hesse, C., Davidsson, P., Wallin, A., Minthon, L., Winblad, B., Vanderstichele, H., Vanmechelen, E. and Blennow, K. (1999) Cerebrospinal fluid b-amyloid(1-42) in Alzheimer's disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch. Neurol., 56, 673-680.
26. Andreasen, N. and Blennow, K. (2002) Beta-Amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease. Peptides, 23, 1205-1214.
27. Soubrier, F., Martin, S., Alonso, A., Visvikis, S., Tiret, L., Matsuda, F., Lathrop, G.M. and Farrall, M. (2002) High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity. Eur. J. Hum. Genet., 10, 553-561.
28. Khoury, M.J., Beaty, T.H. and Cohen, B.H. (1993) Fundamentals of Genetic Epidemiology. Oxford University Press, New York.
29. Cox, R., Bouzekri, N., Martin, S., Southam, L., Hugill, A., Golamaully, M., Cooper, R., Adeyemo, A., Soubrier, F., Ward, R. et al. (2002) Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. Hum. Mol. Genet., 11, 2969-2977.
30. Pritchard, J.K. and Przeworski, M. (2001) Linkage disequilibrium in humans: models and data. Am. J. Hum. Genet., 69, 1-14.
31. Eichner, J.E., Dunn, S.T., Perveen, G., Thompson, D.M., Stewert, K.E. and Stroehla, B.C. (2002) Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am. J. Epidemiol., 155, 487-495.
32. Galasko, D., Chang L., Motter, R., Clark, C.M., Kaye, J., Knopman, D., Thomas, R., Kholodenko, D., Schenk, D., Lieberburg, I. et al. (1998) High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch. Neurol., 55, 937-945.
33. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology, 34, 939-944.
34. Mirra, S.S., Heyman, A. and McKeel, D. (1991) The consortium to establish a registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology, 41, 479-486.
35. Folstein, M., Folstein, S. and McHugh, P. (1975) 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr. Res., 12, 189-198.
36. Kehoe, P.G., Russ, C., McIlory, S., Williams, H., Holmans, P., Holmes, C., Liolitsa, D., Vahidassr, D., Powell, J., McGleenon, B. et al. (1999) Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat. Genet., 21, 71-72,
37. Reuterwall, C., Hallqvist, J., Ahlbom, A., de Faire, U., Diderichsen, F., Hogstedt, C., Pershagen, G., Theorell, T., Wiman, B. and Wolk, A. (1999) Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the SHEEP study, The SHEEP study group. J. Intern. Med., 246, 161-174.
38. Howell, W.M., Jobs, M. and Brookes, A.J. (2002) iFRET: an improved fluorescence system for DNA-melting analysis. Genome Res., 12, 1401-1407.
39. Crawford, F., Abdullah, L., Schinka, J., Suo, Z., Gold, M., Duara, R. and Mullan, M. (2000) Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease. Neurosci. Lett., 280, 215-219.
40. Farrer, L.A., Sherbatich, T., Keryanov, S.A., Korovaitseva, G.I., Rogaeva, E.A., Petruk, S., Premkumar, S., Moliaka, Y., Song, Y.Q., Pei, Y. et al. (2000) Association between angiotensin-converting enzyme and Alzheimer disease. Arch. Neurol., 57, 210-214.
41. Yang, J.D., Feng, G., Zhang, J., Lin, Z.X., Shen, T., Breen, G., St Clair. D. and He, L. (2000) Association between angiotensin-converting enzyme gene and late onset Alzheimer's disease in Han chinese. Neuroscience, 295, 41-44.
42. Cheng, C.Y., Hong, C.J., Liu, H.C., Liu, T.Y. and Tsai, S.J. (2002) Study of the association between Alzheimer's disease and angiotensin-converting enzyme gene polymorphism using DNA from lymphocytes. Eur Neurol., 47, 26-29.
43. Lendon, C.L., Thaker, U., Harris, J.M., McDonagh, A.M., Lambert, J.C., Chartier-Harlin, M.C., Iwatsubo, T., Pickering-Brown, S.M. and Mann, D.M. (2002) The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease. Neurosci. Lett., 328, 314-318.
44. Buss, S., Muller-Thomsen, T., Hock, C., Alberici, A., Binetti, G., Nitsch, R.M., Gal, A. and Finckh, U. (2002) No association between DCP1 genotype and late-onset Alzheimer disease. Am. J. Med. Genet., 114, 440-445.
45. Myllykangas, L., Polvikoski, T., Sulkava, R., Verkkoniemi, A., Tienari, P., Niinisto, L., Kontula, K., Hardy, J., Haltia, M. and Perez-Tur, J. (2000) Cardiovascular risk factors and Alzheimer's disease: a genetic association study in a population aged 85 or over. Neurosci. Lett., 292, 195-198.
46. Hu, J., Miyatake, F., Aizu, Y., Nakagawa, H., Nakamura, S., Tamaoka, A., Takahash, R., Urakami, K. and Shoji, M. (1999) Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population. Neurosci. Lett., 277, 65-67.
47. Alvarez, R., Alvarez, V., Lahoz, C.H., Martinez, C., Pena, J., Sanchez, J.M., Guisasola, L.M., Salas-Puig, J., Moris, G., Vidal, J.A. et al. (1999) Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease. J Neurol. Neurosurg. Psychiat., 67, 733-736.
48. Perry, R.T., Collins, J.S., Harrell, L.E., Acton, R.T. and Go, R.C. (2001) Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am. J. Med. Genet., 105, 332-342.
49. Mattila, K.M., Rinne, J.O., Roytta, M., Laippala, P., Pietila, T., Kalimo, H., Koivula, T., Frey, H. and Lehtimaki, T. (2000) Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology. J. Med. Genet., 37, 766-770.
50. Chapman, J., Wang, N., Treves, T.A., Korczyn, A.D. and Bornstein, N.M. (1998) ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke, 29, 1401-1404.
51. Scacchi, R., De Bernardini, L., Mantuano, E., Vilardo, T., Donini, L.M., Ruggeri, M., Gemma, A.T., Pascone, R. and Corbo, R.M. (1998) DNA polymorphisms of apolipoprotein B and angiotensin I-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer's disease. Dement. Geriatr. Cogn. Disord., 9, 186-190.
52. Palumbo, B., Cadini, D., Nocentini, G., Filipponi, E., Fravolini, M.L. and Senin, U. (1999) Angiotensin converting enzyme deletion allele in different kinds of dementia disorders. Neurosci. Lett., 267, 97-100.
53. Zuliani, G., Ble, A., Zanca, R., Munari, M.R., Zurlo, A., Vavalle, C., Atti, A.R. and Fellin, R. (2001) Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. Acta Neurol. Scand., 103, 304-308.
54. Isbir, T., Agachan, B., Yilmaz, H. and Aydin, M. (2000) Angiotensin converting enzyme gene polymorphism in Alzheimer's disease. Cell Biochem. Funct., 18, 141-142.